C
CERo Therapeutics Holdings, Inc. (CERO)
OQB – Real vaqt narxi. Valyuta: USD
0.03
-0.00 (-12.90%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
OQB – Real vaqt narxi. Valyuta: USD
0.03
-0.00 (-12.90%)
Yopilishda: May 12, 2026, 4:00 PM EDT
CERo Therapeutics Holdings, Inc., immunoterapiya kompaniyasi, saratonni davolash uchun muhandislik qilingan T-hujayrali terapiyalarni ishlab chiqishni rivojlantirishga qaratilgan. Uning yetakchi ishlab chiqish nomzodi CER-1236 bo'lib, gematologik malignite'tlar va qattiq o'smalarni davolash uchun avtolog T-hujayrali terapiya nomzodidir. Kompaniya 2021-yilda tashkil etilgan va Janubiy San-Frantsisko, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Kristen Pierce Ph.D. | Chief Development Officer |
| Dr. Lawrence Corey M.D. | Co-founder & Head of Scientific Advisory Board |
| Mr. Andrew Albert Kucharchuk M.B.A. | Chief Financial Officer |
| Mr. Christopher B. Ehrlich M.B.A. | CEO & Chair |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | 10-K/A | ea0288361-10ka1_cero.htm |
| 2026-04-15 | 10-K | ea0285271-10k_cero.htm |
| 2026-04-14 | 8-K | ea0286319-8k_cero.htm |
| 2026-04-01 | NT 10-K | ea0284239-nt10k_cero.htm |
| 2026-03-11 | 8-K | ea0280905-8k_cero.htm |
| 2026-02-13 | 8-K | ea0276984-8k_ceroa.htm |
| 2026-02-04 | 8-K | ea0275412-8k_cero.htm |
| 2026-02-03 | 8-K | ea0274896-8k_cero.htm |
| 2026-01-07 | 8-K | ea0272086-8k_cero.htm |
| 2025-12-19 | 8-K | ea0270420-8k_cero.htm |